Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes (Q44283353)

1 December 2017

Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes (English)

1 reference

1 December 2017

1 reference

1 reference

1 reference

1 reference

3

Olov Wiklund

1 reference

1 December 2017

Marja-Riitta Taskinen

6

object named as

Marja-Riitta Taskinen

1 reference

1 December 2017

Eeva Leinonen

1

1 reference

1 December 2017

Eva Hurt-Camejo

2

1 reference

1 December 2017

Lillemor Mattson Hultén

4

1 reference

1 December 2017

Anne Hiukka

5

1 reference

1 December 2017

1 February 2003

1 reference

1 December 2017

1 reference

1 December 2017

166

1 reference

1 December 2017

387-394

1 reference

1 December 2017

2

1 reference

Atherosclerosis — An Inflammatory Disease

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Analysis of secretory group II phospholipase A2 expression in human aortic tissue in dependence on the degree of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Level of circulating phospholipase A2 in prediction of the prognosis of patients with suspected myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Adenovirus-mediated gene transfer of macrophage colony stimulating factor to the arterial wall in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Cellular adhesion molecules and atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Insulin sensitivity and its measurement: structural commonalities among the methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Clinical significance of the insulin resistance index as assessed by homeostasis model assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Is visceral adiposity the "enemy within"?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Phospholipase A(2) in vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Effects of inflammation on high-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Remodelling of high density lipoproteins by plasma factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Infection and inflammation-induced proatherogenic changes of lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Lipolysis of LDL by Human Secretory Phospholipase A 2 Induces Particle Fusion and Enhances the Retention of LDL to Human Aortic Proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Cell adhesion molecules and secretory type II phospholipase A2 in relation to carotid atherosclerosis in patients with hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Increased levels of monocyte-related cytokines in patients with unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

Anti-inflammatory mechanisms in the vascular wall.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900371-4

10.1016/S0021-9150(02)00371-4

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference